Belite Bio (BLTE) News Today $62.70 +0.67 (+1.07%) As of 07/11/2025 04:00 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock BLTE Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 Time Period Leerink Partnrs Weighs in on Belite Bio FY2029 EarningsJuly 11 at 2:24 AM | americanbankingnews.comQ2 EPS Estimates for Belite Bio Decreased by Leerink PartnrsJuly 11 at 2:13 AM | americanbankingnews.comBelite Bio (NASDAQ:BLTE) Shares Gap Down - What's Next?July 10 at 12:21 PM | marketbeat.comLeerink Partnrs Has Weak Estimate for Belite Bio Q2 EarningsJuly 10 at 8:17 AM | marketbeat.comLeerink Partnrs Comments on Belite Bio FY2029 EarningsJuly 9 at 8:41 AM | marketbeat.comBelite Bio (NASDAQ:BLTE) Sees Large Volume Increase - Here's What HappenedJuly 7, 2025 | marketbeat.comHC Wainwright Reiterates "Buy" Rating for Belite Bio (NASDAQ:BLTE)July 5, 2025 | americanbankingnews.comBelite Bio's (BLTE) "Buy" Rating Reaffirmed at HC WainwrightJuly 3, 2025 | marketbeat.comBelite Bio Announces Completion of Enrollment in the Pivotal Global Phase 3 PHOENIX Trial Evaluating Oral Tinlarebant in Geographic AtrophyJuly 2, 2025 | globenewswire.comBelite Bio (NASDAQ:BLTE) Sees Large Volume Increase - Time to Buy?June 30, 2025 | marketbeat.comBelite Bio, Inc (NASDAQ:BLTE) Sees Large Growth in Short InterestJune 17, 2025 | marketbeat.comBelite Bio (NASDAQ:BLTE) Sees Unusually-High Trading Volume - Should You Buy?June 17, 2025 | marketbeat.comAnalysts Set Expectations for Belite Bio FY2026 EarningsJune 11, 2025 | marketbeat.comBelite Bio (NASDAQ:BLTE) Sees Unusually-High Trading Volume - Here's What HappenedJune 9, 2025 | marketbeat.comGAMMA Investing LLC Raises Stock Holdings in Belite Bio, Inc (NASDAQ:BLTE)June 9, 2025 | marketbeat.comBank of America Corp DE Acquires 4,891 Shares of Belite Bio, Inc (NASDAQ:BLTE)June 7, 2025 | marketbeat.comBelite Bio (NASDAQ:BLTE) Stock Price Down 4.1% - Here's WhyJune 6, 2025 | marketbeat.comBelite Bio, Inc (NASDAQ:BLTE) Short Interest Up 23.0% in MayJune 3, 2025 | marketbeat.comBelite Bio (NASDAQ:BLTE) Trading Up 5.3% - Should You Buy?May 30, 2025 | marketbeat.comWhat is HC Wainwright's Estimate for Belite Bio Q1 Earnings?May 25, 2025 | marketbeat.comBelite Bio stock holds $80 target on FDA breakthrough nodMay 23, 2025 | investing.comBelite Bio (NASDAQ:BLTE) Shares Gap Up - Time to Buy?May 23, 2025 | marketbeat.comBelite Bio, Inc: Belite Bio Announces FDA Granting of Breakthrough Therapy Designation for Tinlarebant for the Treatment of Stargardt DiseaseMay 21, 2025 | finanznachrichten.deBelite Bio Announces FDA Granting of Breakthrough Therapy Designation for Tinlarebant for the Treatment of Stargardt DiseaseMay 21, 2025 | globenewswire.comFY2025 EPS Estimates for Belite Bio Cut by Cantor FitzgeraldMay 21, 2025 | marketbeat.comQ2 Earnings Estimate for Belite Bio Issued By HC WainwrightMay 20, 2025 | marketbeat.comBelite Bio stock retains Overweight rating at Cantor FitzgeraldMay 17, 2025 | uk.investing.comWe're Not Worried About Belite Bio's (NASDAQ:BLTE) Cash BurnMay 16, 2025 | finance.yahoo.comBelite Bio signals positive DSMB review and targets 500-patient PHOENIX trial enrollment completion in Q3 2025 while maintaining strong cash runwayMay 16, 2025 | msn.comBelite Bio Inc (BLTE) Q1 2025 Earnings Call Highlights: Strong Financial Position Amid Rising ...May 16, 2025 | finance.yahoo.comBelite Bio: Investors Face Tricky Decision Ahead Of Key STGD1 Study ReadoutMay 15, 2025 | seekingalpha.comBelite Bio Advances Tinlarebant Trials with Positive Interim ResultsMay 14, 2025 | tipranks.comEarnings Outlook For Belite BioMay 14, 2025 | benzinga.comBelite Bio Reports First Quarter 2025 Financial Results and Provides Corporate UpdateMay 13, 2025 | globenewswire.comBelite Bio, Inc to Present at the dbVIC – Deutsche Bank ADR Virtual Investor Conference May 15thMay 12, 2025 | financialpost.comFBelite Bio, Inc to Present at the dbVIC – Deutsche Bank ADR Virtual Investor Conference May 15thMay 12, 2025 | financialpost.comFBelite Bio, Inc to Present at the dbVIC - Deutsche Bank ADR Virtual Investor Conference May 15thMay 12, 2025 | globenewswire.comBelite Bio to Participate in Four Upcoming Investor ConferencesMay 12, 2025 | globenewswire.comBelite Bio, Inc American Depositary Shares (BLTE)May 10, 2025 | nasdaq.comBelite Bio (BLTE) to Release Quarterly Earnings on MondayMay 7, 2025 | marketbeat.comBelite Bio (NASDAQ:BLTE) Sees Unusually-High Trading Volume - Time to Buy?May 1, 2025 | marketbeat.comBelite Bio, Inc (NASDAQ:BLTE) Shares Purchased by JPMorgan Chase & Co.April 30, 2025 | marketbeat.comBelite Bio, Inc (NASDAQ:BLTE) Sees Significant Drop in Short InterestApril 21, 2025 | marketbeat.comLeerink Partnrs Expects Reduced Earnings for Belite BioApril 18, 2025 | marketbeat.comBelite Bio (NASDAQ:BLTE) Stock Price Down 7.2% - Time to Sell?April 11, 2025 | marketbeat.comBelite Bio, Inc. Appoints New AuditorMarch 28, 2025 | tipranks.comBelite Bio price target raised to $80 from $79 at BenchmarkMarch 27, 2025 | markets.businessinsider.comBelite Bio (NASDAQ:BLTE) Shares Gap Up - Here's What HappenedMarch 27, 2025 | marketbeat.comBenchmark Reiterates Buy Rating for Belite Bio (NASDAQ:BLTE)March 27, 2025 | marketbeat.comFY2025 EPS Forecast for Belite Bio Decreased by AnalystMarch 21, 2025 | marketbeat.com Get Belite Bio News Delivered to You Automatically Sign up to receive the latest news and ratings for BLTE and its competitors with MarketBeat's FREE daily newsletter. Email Address BLTE Media Mentions By Week BLTE Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BLTE News Sentiment▼0.641.00▲Average Medical News Sentiment BLTE News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BLTE Articles This Week▼133▲BLTE Articles Average Week Get Belite Bio News Delivered to You Automatically Sign up to receive the latest news and ratings for BLTE and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies ELAN News RVMD News LEGN News GRFS News TGTX News NUVL News LNTH News TLX News AXSM News AKRO News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:BLTE) was last updated on 7/12/2025 by MarketBeat.com Staff From Our PartnersTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredWhich Gold Miner Trades at 30% of NAV? The One Buffett WantsSome of the world’s best gold developers are trading at just 30% of NAV — like buying a dollar for 30 cents. ...Golden Portfolio | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBank of America Says Gold Could Hit $4,000. Here How to Get PaidBank of America believes gold could hit $4,000 an ounce in the next 12 months. That's an 18% jump from toda...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Belite Bio, Inc. Sponsored ADR Please log in to your account or sign up in order to add this asset to your watchlist. Share Belite Bio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free BLTE Stock Alerts